Crossmark

TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients

Published Online: 2021-06-28

Published Print: 2021-12

Authors

Monlezun, Dominique J. https://orcid.org/0000-0001-7671-1886
Hostetter, Logan

Balan, Prakash

Palaskas, Nicolas

Lopez-Mattei, Juan

Cilingiroglu, Mehmet

Iakobishvili, Zaza

Ewer, Michael

Marmagkiolis, Konstantinos

Iliescu, Cezar
License Information

Text and Data Mining valid from 2021-06-28

Version of Record valid from 2021-06-28
More Information

Article History

Received: 4 November 2020

Accepted: 3 June 2021

First Online: 28 June 2021

Declarations

:

: Ethics approval and patient consent was deemed not required due to this study’s dataset that consisted of the National Inpatient Sample de-identified administrative database.

: All authors consented to submission and if accepted then also publication of this manuscript.

: The authors have no competing interests.

Document is current